EZH2 and acute myeloid leukemia: Low EZH2 protein levels in AML can be due to inactivating mutations in about 2% of adult AML [156], but more often this decrease is dependent on post-translational dysregulation of the protein, triggered by EZH2 phosphorylation induced by CDK1 and subsequent proteasomal degradation.